Low-level light therapy, also called photobiomodulation (PBM), has emerged as a promising approach to Alzheimer's treatment, ...

New research has revitalized interest in the longstanding link between brain trauma and dementia by focusing on the vascular ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

TOKYO, Feb 14, 2025 - (JCN Newswire) - - Oita University and Eisai Co., Ltd. (Eisai) announced today the development of a machine learning model to predict amyloid beta(1)(Abeta) accumulation in ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...